Complix

Ablynx NV

This company develops nanobody-based therapeutic proteins to treat inflammation, haematology, oncology and pulmonary diseases for pharmaceutical partners and patients.

UbiquiTx

This company develops a programmable protein modulation platform using artificial intelligence to create targeted therapies for pharmaceutical businesses and patients with complex diseases.

Precirix

This biotechnology company develops precision radiopharmaceuticals using camelid single-domain antibodies to treat patients with various types of cancer.

Accipiter Biosciences

Accipiter Biosciences develops custom-engineered protein therapies using computational design to treat complex diseases like cancer and autoimmune disorders for the healthcare sector.

Commit Biologics

This biotechnology firm develops a platform for creating bispecific complement engagers to treat cancer and autoimmune diseases for the pharmaceutical industry.

Confluence Life Sciences

This biopharmaceutical company develops kinase inhibitors to treat inflammatory disorders and cancer for pharmaceutical and biotechnology industries.

Apoxis SA

This company develops therapeutic proteins and small molecules for the treatment of cancer and inflammatory diseases in clinical-stage patients.

STipe Therapeutics

The company develops drugs targeting protein-protein interactions within the STING pathway to treat cancer and autoimmune diseases for healthcare institutions and pharmaceutical firms.